Puma Biotechnology Inc - Common Stock - fluxo de caixa trimestral (NASDAQ:PBYI) | MetaTrader

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Fluxo de caixa operacional 15.61 M3.61 M14.08 M9.69 M14.42 M15.42 M 53.61 M Fluxo de caixa de investimento -2.32 M1.53 M-11.25 M506 K-26.98 M2.47 M -35.24 M Fluxo de caixa de financiamento -11.33 M-11.33 M-11.2 M-11.33 M-11.33 M-11.33 M -45.2 M Fluxo de caixa livre 15.61 M3.61 M14.06 M9.66 M14.46 M15.42 M 53.6 M

Puma Biotechnology Inc - Common Stock

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Notícias

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Puma Biotechnology, Inc. (PBYI) Q1 2026 Earnings Call Transcript

Puma Biotechnology, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-05-08

Transcrição do call de resultados: Puma Biotech perde previsões de LPA e receita no 1º tri de 2026

Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Beats Revenue Estimates

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

Receita do NERLYNX da Puma Biotechnology sobe 15% no 4º tri de 2025

Puma Biotechnology reporta resultados robustos no 4º tri de 2025

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?